Structural determinants for histamine H1 affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs

被引:12
作者
Aslanian, Robert [1 ]
Piwinski, John J. [1 ]
Zhu, Xiaohong [1 ]
Priestley, Tony [1 ]
Sorota, Steve [1 ]
Du, Xiao-Yi [1 ]
Zhang, Xue-Song [1 ]
McLeod, Robbie L. [1 ]
West, Robert E. [1 ]
Williams, Shirley M. [1 ]
Hey, John A. [1 ]
机构
[1] Schering Plough Res Inst, Kenilworth, NJ 07033 USA
关键词
Antihistamine; Terfenadine; Astemizole; Torsades de pointes; hERG; H-1; MUTATIONAL ANALYSIS; POTASSIUM CHANNEL; GUINEA-PIGS; DE-POINTES; DRUGS; RECEPTOR; ANTIHISTAMINES; ANTAGONIST; INSIGHTS; INTERVAL;
D O I
10.1016/j.bmcl.2009.07.047
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
In the late 1980's reports linking the non-sedating antihistamines terfenadine and astemizole with torsades de pointes, a form of ventricular tachyarrhythmia that can degenerate into ventricular fibrillation and sudden death, appeared in the clinical literature. A substantial body of evidence demonstrates that the arrhythmogenic effect of these cardiotoxic antihistamines, as well as a number of structurally related compounds, results from prolongation of the QT interval due to suppression of specific delayed rectifier ventricular K+ currents via blockade of the hERG-IKr channel. In order to better understand the structural requirements for hERG and H-1 binding for terfenadine, a series of analogs of terfenadine has been prepared and studied in both in vitro and in vivo hERG and H-1 assays. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5043 / 5047
页数:5
相关论文
共 17 条
[1]
*ACS, 2003, 230 ACS M NO LA MARC
[2]
Biochemical characterization of desloratadine, a potent antagonist of the human histamine H1 receptor [J].
Anthes, JC ;
Gilchrest, H ;
Richard, C ;
Eckel, S ;
Hesk, D ;
West, RE ;
Williams, SM ;
Greenfeder, S ;
Billah, M ;
Kreutner, W ;
Egan, RW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 449 (03) :229-237
[3]
Mutational analysis of the histamine H1-receptor binding pocket of histaprodifens [J].
Bruysters, M ;
Pertz, HH ;
Teunissen, A ;
Bakker, RA ;
Gillard, M ;
Chatelain, P ;
Schunack, W ;
Timmerman, H ;
Leurs, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 487 (1-3) :55-63
[4]
Toward a pharmacophore for drugs inducing the long QT syndrome:: Insights from a CoMFA study of HERG K+ channel blockers [J].
Cavalli, A ;
Poluzzi, E ;
De Ponti, F ;
Recanatini, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (18) :3844-3853
[5]
QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience [J].
De Ponti, F ;
Poluzzi, E ;
Montanaro, N .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (01) :1-18
[6]
De Ponti F, 2002, DRUG SAFETY, V25, P263
[7]
New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies [J].
Farid, R ;
Day, T ;
Friesner, RA ;
Pearlstein, RA .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (09) :3160-3173
[8]
ANTIHISTAMINE ACTIVITY, CENTRAL-NERVOUS-SYSTEM AND CARDIOVASCULAR PROFILES OF HISTAMINE H-1 ANTAGONISTS - COMPARATIVE-STUDIES WITH LORATADINE, TERFENADINE AND SEDATING ANTIHISTAMINES IN GUINEA-PIGS [J].
HEY, JA ;
DELPRADO, M ;
CUSS, FM ;
EGAN, RW ;
SHERWOOD, J ;
LIN, CC ;
KREUTNER, W .
CLINICAL AND EXPERIMENTAL ALLERGY, 1995, 25 (10) :974-984
[9]
Molecular Determinants of hERG Channel Block by Terfenadine and Cisapride [J].
Kamiya, Kaichiro ;
Niwa, Ryoko ;
Morishima, Mikio ;
Honjo, Haruo ;
Sanguinetti, Michael C. .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 108 (03) :301-307
[10]
A structural basis for drug-induced long QT syndrome [J].
Mitcheson, JS ;
Chen, J ;
Lin, M ;
Culberson, C ;
Sanguinetti, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) :12329-12333